1.Effects of 8 - Methoxypsoralen ( 8 - MOP ) on the Proliferation and Melanization of Cultured Normal Human Melanocytes without UVA.
My Hyoung LEE ; Han Dong YOO ; Jai Kyung PARK ; Choong Rim HAW
Korean Journal of Dermatology 1994;32(5):832-837
BACKGROUND: Psoralen has been used in the treatment of certain hypojigmentary disorders with UVA or solar irradiation. However trecent report proposed the actions of psiralens are direct and do not require the presence of ultraviolet light. The report also suggested that tze specific receptors other than DNA would be present. OBJECTIVE: This study was done ta identify the effects of 8-methoryporalen(8-MOP) on the proliferation and melanization of cultured normal human melanocytes without UVA. METHODS: Melanocytes were cultured in melanocyte culture medium neluding 16% or 5% FBS. We added 8-MOP by their concentrations from 10 M to 10 M. After 8 hours treatment, we investigated the melanocytes proliferation and Lhe melanin contents. RESULTS: We could not detecet any significant differences of melanoytes proliferation and melanin contents between the control end experimental groups. CONCLUSION: There were no effect on the proliferation and the milanization of cultured normal human melanocytes with 8-MOP only.
DNA
;
Ficusin
;
Humans*
;
Melanins
;
Melanocytes*
;
Methoxsalen
;
Ultraviolet Rays
2.Effects of Kainic Acid-induced Seizures on c-fos Protein Expression in the Rat Hippocampus.
Kyung My YOO ; Kwang Soo KIM ; Moo Youn CHO ; Byung Chae PARK
Journal of the Korean Neurological Association 1996;14(1):102-113
C-fos protein is a gene regulatory third messenger involved in long-term responses of cells to various stimuli. Kainic acid(KA), a powerful excitatory analogue, induces seizures and damages the hippocampus and other limbic regions in rats. KA treatment induces c-fos protein production in the hippocampus. This study was undertaken to investigate the expression of c-fos protein in the hippocampus according to seizure stage induced by systemic injection of KA. Twenty-three adult male Sprague-Dawley rats experienced convulsions by a single intraperitoneal injection of convulsive dose (20-40 mg/Kg) of KA. Seven control rats received normal saline. Animals were sacrificed 3 hr after KA treatment. The expression of c-fos protein was tested in the hippocampus by immunohistochemical staining using polyclonal anti-Fos. Most of the rats exhibited limbic motor epileptic activity. C-fos protein immunoreactivity increased in the CA1, CA3 and dentate gyrus at stage 1-2, and not only in the CA1, CA3 and dentate gyrus but also in the CA4 at stage 3-4. At stage 5, c-fos protein immunoreactivity increased in all areas of the hippocampus. C-fos protein immunoreactivity increased progressively with increasing severity of convulsions. These results show that KA produces limbic motor seizure associated with a rise in the c-fos protein in the hippocampus, and that the expression of c-fos protein may has some relevance to the progressive and permanent brain changes occurring during epilepsy.
Adult
;
Animals
;
Brain
;
Dentate Gyrus
;
Epilepsy
;
Genes, vif
;
Hippocampus*
;
Humans
;
Injections, Intraperitoneal
;
Male
;
Rats*
;
Rats, Sprague-Dawley
;
Seizures*
3.Amorolfine Nail Lacquer 5 % Once Weekly in Onychomycosis of Fingers and / or Toes.
Hee Chul EUN ; My Hyoung LEE ; Soo Nam KIM ; Hee Joon YOO ; Kyung Sool KWON ; Soo Chan KIM ; Jae Seung LEE ; Bang Soon KIM ; Byoung Soo CHUNG ; Seung Ho CHANG ; Chun Wook PARK
Korean Journal of Dermatology 1995;33(2):314-321
BACKGROUND: Amorolfine is a new topical antifungal drug of the morpholine class has broad spectrum fungicidal activity. Amorolfine nail lacquer 5% is a transungual delivery system which can penetrate well through the nail plate to the infected keratin and remain there for a prolonged period. OBJECTIVE: The aim of this study is to assess the efficacy and tolerability of 5% amorolfine nail lacquer given once weekly to the patients with onychomycosis. METHODS: 29 patients with onychomycosis affecting not more than 80% of the surface of nail were treated once weekly for up to 9 months with amorolfine nail lacquer 5%. Clinical and mycological examination were performed before treatment and 3, 6, 9 months after start of treatment. Final evaluation was done 3 months after the end of treatment. RESULTS: Average affected area(%) and average score of clinical signs-thickening, splitting, discoloration-were significantly decreased 3 months after start of treatment. Mycological cure rate was continuously increased according to the treatment duration reaching 75.9% at 3 months after treatment. Overall efficacy assessed by the investgators were cure in 31.0% and improvement in 41.4%. Tolerability, mode and frequency of treatment, and formulation were evaluated as good or excellent by most of the patients.No systemic or local side effect was observed. CONCLUSION: Amorolfine nail lacquer 5% used once weekly up to 9 months was relatively effective and safe for the treatment of onychomycosis.
Fingers*
;
Humans
;
Lacquer*
;
Onychomycosis*
;
Toes*